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Abstract 
The relationship between the tetrameric organization of the ryanodine receptor (RyR) and its activity in binding of ryanodine was 
approached through cross-linking studies using several bifunctional reagents, differing in their linear dimensions and flexibility, as well as 
in the reactivity of the active groups. Cross-linking with: 1,5-difluoro-2,4-dinitrobenzene (DFDNB); di(fluoro-3-nitrophenyl)sulfone 
(DFNPS), 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide (EDC); dimethyl suberimidate (DMS); ethylene glycol bis(succinimidylsuc- 
cinate) (EGS); and glutaraldehyde r sulted in the disappearance of the, 470 kDa, RyR monomer protein band with concomitant 
appearance ofadditional bands of molecular masses higher than the monomer. At the relatively low concentrations of the reagents and the 
conditions used, RyR is the only cross-linked protein of SR membranes. The 'new' protein bands cross-react with antibodies against he 
RyR and correspond to dimers and tetramers of the RyR subunits while trimers were not detectable. DFDNB and DFNPS produced also a 
560 kDa protein band which probably represents an intramolecular c oss-linked monomer. The SDS-electrophoretic patterns of the 
cross-linked purified RyR resemble those of the membrane-bound receptor. Ryanodine binding to the high-affinity site was inhibited by 
modification of SR membranes with DFDNB and DFNPS, but not with DMS, EDC, EGS and glutaraldehyde, although RyR was 
completely cross-linked. The inhibition by DFDNB and DFNPS is due to modification of a specific lysyl residue which is also involved 
in the control of Ca 2 ÷ release. On the other hand, cross linking of the RyR with glutaraldehyde or EGS resulted in inhibition of ryanodine 
binding to the low-affinity, but not to the high-affinity binding sites. Thus, the cross-linking of two or more sites in each monomer (which 
lead to fixation of dimers or tetramers) did not prevent the conformational changes involved in the binding and occlusion of ryanodine at 
the high-affinity site, but inhibited its binding to the low-affinity sites. 
Keywords: Sarcoplasmic reticulum; Ryanodine r ceptor; Cross-linking 
1. Introduction 
Depolarization of skeletal muscle cell membranes initi- 
ates a series of events, which result in the release of Ca 2÷ 
Abbreviations: EDC, 1-ethyl-3-(3-(dimethylamino)propyl)carbo- 
diimide; EDTA, ethylenediaminetetraacetic id; EGTA, ethylene glycol 
bis(/3-aminoethyl ether)-N,N,N',N'-tetraacetic acid; Tricine, N-(2-hy- 
droxy-l,l-bis(hydroxymethyl)ethyl)glycine; Mops, 3-(N-morpholino)pro- 
panesulfonic acid; SDS-PAGE, sodium dodecyl sulfate polyacrylamide 
gel electrophoresis; SR, sarcoplasmic reticulum; DFDNB, 1,5-difluoro- 
2,4-dinitrobenzene; DFNPS, di(4-fluoro-3-nitrophenyl)sulfone; DMS, 
dimethyl suberimidate; DNFB, 1-fluoro-2,4-dinitrobenzene; EGS, ethy- 
lene glycol bis(succinimidylsuccinate); DMSO, dimethyl sulfoxide; DTI', 
dithiothreitol; FITC, fluorescein 5'-isothiocyanate; RyR, ryanodine r cep- 
tor. 
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from the sarcoplasmic reticulum (SR) via Ca 2+ regulated 
ion channels [1,2]. These channels are characterized by 
their ability to bind ryanodine [3,4], a plant toxic alkaloid. 
The purified ryanodine binding protein consists of high 
molecular weight polypeptides (~ 450 kDa), which are 
assembled into tetrameric omplexes of apparent sedimen- 
tation coefficient of 30 S [5,6]. Quantitative analysis of 
[3H]ryanodine binding to the purified 30 S receptor indi- 
cated a stoichiometry of one high affinity site per tetramer 
[7], A tetrameric assembly of subunits for the ryanodine 
receptor was also suggested from ultra structural analysis 
using scanning transmission electron microscopy [7-9]. 
When incorporated into planar lipid bilayers, the purified 
protein exhibited a calcium conductance with pharmaco- 
logical properties of the native SR Ca 2+ release channel 
[9-11]. Structural analysis of the purified receptor suggests 
that it corresponds to the junctional feet structures which 
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span the gap between SR junctional face membranes and 
the transverse tubule [12]. Cloning and sequence analysis 
of the cDNA [13-15] have completed the molecular pic- 
ture of this membrane protein, and a molecular mass of 
565 kDa was determined. 
An important biophysical characteristic of the ryanodine 
receptor/Ca 2+- release channel is its organization i to an 
oligomeric omplex and the relationship between this orga- 
nization and its activities both as a ryanodine binding 
protein and a Ca 2 +-release channel. One approach to study 
these relationships i the use of chemical cross-linking. 
The use of a cross-linker provided the possibility of 
investigating the arrangement of protein components in a 
complex, to determine the nearest neighbor relationships of 
membrane components and to study the structure-function 
relationships. In this paper, using several cross-linking 
reagents, the ryanodine receptor was cross-linked into 
dimers, tetramers and other intramolecular cross-linked 
species. This covalent cross-linking of the ryanodine recep- 
tor does not interfere with its ryanodine binding activity to 
the high-affinity site but prevents the binding to the low- 
affinity sites. 
2. Experimental procedures 
2.1. Materials 
Glutaraldehyde, ATP, DFDNB, DFNPS, EGTA, Mops, 
Tricine, DMS and FDNB were obtained from Sigma. EDC 
and EGS were obtained from Pierce. [3H]Ryanodine (60 
Ci/mmol), and 45CAC12 were purchased from New Eng- 
land Nuclear. Unlabeled ryanodine was obtained from 
Calbiochem. 
2.2. Membrane and purified ryanodine receptor prepara- 
tions 
reaction was carried out for 2 to 30 min at 37°C and 
terminated by the addition of DTT to a final concentration 
of 1 mM after which the samples were transferred to ice. 
The SR treatment with EDC or DMS was carried out for 
30 rain at 30°C in 50 mM imidazole, pH 7.0 or 20 mM 
Tricine, pH 8.6, respectively. The treatment with EGS 
(freshly prepared in DMSO) was carried out for 10 min at 
24 ° C in 50 mM NaP~, pH 7.2. The reaction was terminated 
by the addition of glycine to a final concentration of 40 
mM. Aliquots were tested for ryanodine binding or pro- 
cessed for SDS-polyacrylamide g l electrophoresis a de- 
scribed below. SR vesicles were also modified with the 
reagents, under different conditions, as indicated in figure 
and table legends. DFDNB was prepared in 50% ethanol 
and DFNPS and FDNB were dissolved in DMSO. The 
final concentration of ethanol or DMSO in control and 
reagents containing samples was 2% (v/v)  or less. DMS 
was dissolved in distilled water and the pH was adjusted to 
about 8.0. 
2.4. [ 3H]Ryanodine binding 
Unless otherwise specified, control or modified SR 
membranes (final concentration f 0.5 mg/ml) were incu- 
bated for 1 to 2 h at 37 ° C with 20 nM [3H]ryanodine in a 
standard binding solution containing 1.0 M NaC1, 20 mM 
Mops, pH 7.4 and 50/xM CaC12. Unbound ryanodine was 
separated from protein-bound ryanodine by filtration of 
protein aliquots (50 /xg) through Whatman GF/C  filters, 
followed by three washings with 5 ml of ice cold buffer 
containing 0.2 M NaCI, 5 mM Mops, pH 7.4 and 50 /xM 
CaCI 2. The filters were dried and the retained radioactivity 
was determined by standard liquid scintillation counting 
techniques. Non specific binding was determined in the 
presence of 20 /zM unlabeled ryanodine. 
2.5. Gel electrophoresis 
Junctional SR membranes were prepared from rabbit 
fast-twitch skeletal muscle as described by Saito et al. [16] 
and the fraction R 4 was  used in most of the experiments. 
The membranes were suspended to a final concentration f
about 25 mg protein/ml in a buffer containing 0.25 M 
sucrose, 10 mM Tricine, pH 8.0 and 1 mM histidine, and 
stored at - 70 ° C. Protein concentration was determined by 
the method of Lowry et al. [17]. Ryanodine receptor was 
purified by the spermine-agarose method [18], and its 
protein concentration was determined as described previ- 
ously [19]. 
2.3. Modification of SR membranes with the cross-linking 
reagents 
Freshly prepared DFDNB, DFNPS and glutaraldehyde 
solutions were added to a mixture containing 20 mM 
Tricine, pH 8.0 and SR membranes (1 to 2 mg/ml). The 
The modified and unmodified membranes were diluted 
with 1/3 volume of buffer containing 260 mM Tris-HC1, 
pH 6.8, 40% (v/v)  glycerol, 8% (w/v)  SDS, 4% (v/v)  
/3-mercaptoethanol and incubated for 3 min at 100 ° C. 
The analysis of protein profile by SDS-polyacrylamide 
slab gel electrophoresis was performed using Laemmli's 
[20] discontinuous buffer system in 1.5 mm thick slab gels 
with 3-13%, 3-6% or 2.6-6% acrylamide, using 3% or 
2.6% stacking gel. Gels were stained with Coomassie 
brilliant blue. Molecular weight standards were: myosin, 
200 000; /3-galactosidase, 116 000; phosphorylase b, 
97400; bovine serum albumin, 66200; and ovalbumin, 
42700 (Bio-Rad), and the phosphorylase b cross-linked 
(97 to 873 kDa, monomer to octamer, Sigma). Quantitative 
analysis of the protein bands was determined by densito- 
metric scanning of the Coomassie stained gels, using a 
Molecular Dynamics computing densitometer and Image- 
Quant software provided by the manufacturer. 
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3. Results 
Partial chemical cross-linking of polypeptides in 
oligomeric proteins results in the formation of dimers, 
trimers etc., which can be detected by SDS-PAGE [21,22]. 
However,  intra-molecular cross- l inking within the 
monomer was also observed in several proteins [23-25]. 
Fig. 1 shows the effect of preincubation of SR mem- 
branes with DFDNB, at relatively low concentration (0.5-  
50/zM) ,  on the pattern of the SR polypeptides, as revealed 
by SDS-PAGE. As can be seen, the cross-linking of the 
SR membranes by DFDNB resulted in the disappearance 
of the 470 kDa protein band; ryanodine receptor monomer, 
with concomitant appearance of additional four bands of 
higher molecular masses than the monomer. At the rela- 
tively low concentrations of the reagent and the conditions 
used, ryanodine receptor is the only protein of the SR 
membranes that is cross-linked by DFDNB (Fig. 1A). For 
better demonstration of the cross-linking products (labeled 
a to d) the DFDNB-treated samples were also subjected to 
SDS-PAGE in linear gradient gels of relatively low con- 
centrations of acrylamide; 3 -6% (Fig. 1B) and 2.6-6% 
(Fig. 1C). An increase in the concentration of the cross-lin- 
king reagent leads to an increase in the number of bands, 
and in changes in their intensities (analyzed in Fig. 4). 
Like the RyR and its degradation product (350 kDa) the 
'new' protein bands (a-d)  cross react with polyclonal 
antibodies, prepared against the 470 kDa protein bands 
(RyR) cuts from gels and injected into guinea-pigs [39], 
suggesting that they are derived from the RyR (Fig. 2). No 
cross reactivity was obtained with antibodies prepared 
against the Ca2+-ATPase (E52), sarcalumenin (G7 and 
G10, provided by Dr. D.H. MacLennan) or triadin (data 
not shown). 
Due to the large molecular mass of these protein bands, 
precise molecular weights could not be accurately deter- 
mined. Using the presently available molecular weight 
standards (see Experimental procedures), the cross-linking 
products (bands a to d) corresponded to relative molecular 
A B 
Amido  B lack  Immunob lo t  
DFDNB, ~tM: 0 10 20 0 10 20 d 
470k a 4 7 0 k ~ ~-~; -a  
Ca2+-ATPase 
Fig. 2. [mmunoenzymatic staining of the cross-linking products with 
anti-470 kDa antibodies. (A) Amido-black staining; (B) Immunoblot. SR 
membranes (1 mg/ml) were incubated without (control) or with 10 and 
20 p~M of DFDNB lbr 5 rain as described inFig. 1. Aliquots (20 p,g) of 
the treated membranes were subjected to SDS-PAGE (2.6-6% acryl- 
amide), followed by immunoblot analysis. Western blot analysis was 
carried out as described previously [38]. The separated proteins from 
SDS-PAGE were electrophoretically transferred onto Immobilon (PVDF) 
membranes. The membranes were blocked with 5% nonfat dry milk and 
0.1% Tween-20 in Tris-buffered satine, incubated with anti ryanodine 
receptor antibodies (1:500) and then with alkaline-phosphatase-con- 
jugated protein A. The color was then developed (5min) with 5-bromo- 
4-chloro-3-indolylphosphate and Nitro blue tetrazolium. Antibodies 
against the RyR were prepared as described previously [39]. Bands (a) to 
(d) are as in Fig. 3. 
masses of 560, ~ 1000 and two bands of above 1000 kDa. 
This suggests that not all the bands represent covalent 
cross-linking between individual members of the ryan- 
odine receptor complex. The 560 kDa band probably re- 
flects an intramolecular (intersubunit) cross-linking which 
alters the mobility of the monomer (apparent M r of 
470000). However, we cannot rule out cross-linking be- 
tween ryanodine receptor monomer and neighboring pro- 
tein(s) suggested to be part of the foot structures [26,27]. 
The I000 kDa band probably corresponds to the dimer. 
and the other two high molecular masses bands could be 
A.  3-13% B.  3 -6  % C .  2.6.6% 
DFDNB ,,., =, 
470t. . . . . . . . . . . .  • 
470k ~ 
--b 
- -a  
470k ~ 
Fig. 1. SDS-PAGE profiles of SR membranes cross-linked with DFDNB. SR membranes (1.0 mg/ml) were incubated without or with the indicated 
concentration f DFDNB in 20 mM Tricine, pH 8.0. After 15 min at 37 ° C. DTT was added to a final concentration f 1 raM. Aliquots of the treated 
membranes (50 /zg) were solubilized in SDS-buffer and subjected to 3-13% (A) or 3-6% (B) and 2.6-6% (C) SDS-PAGE as described under 
Experimental procedures. Full and open arrows indicate Ca2+-ATPase and calsequestrin, respectively. 










. . . . . .  .N ' . ' .  ,.N 
0.1 0.2 0A 0.7 
Relative mobility 
Fig. 3. Estimation of the apparent oligomeric state of the DFDNB 
cross-linking products in SDS-PAGE gels. SR membranes (1 mg/ml)  
were treated with DFDNB and subjected to SDS-PAGE. The mobilities 
of the Coomassie-blue stained bands observed in the SDS-PAGE gels 
were calculated relative to that of the Bromophenol blue tracking dye, 
and were plotted as a function of the logarithm of their assigned 
monomer copy numbers [22]. The monomer copy numbers assigned to 
the individual bands are: 470 kDa is the monomer, band (b) = dimer, and 
band (c) = tetramer. The positions of (a) and (d) are also indicated. A plot 
of the relative mobility of the phosphorylase b cross-linking products as a 
function of the logarithm of their monomer copy numbers is also pre- 
sented, The results are the average of analysis of several gels. 
trimers and tetramers. To test this proposal, a plot analysis 
of the logarithm of the assumed copy numbers versus the 
logarithm of the relative mobility of each of the bands [22] 
was carried out. The analysis of the RyR cross-linked 
products in several gels, and for comparison of a known 
cross-linked protein; phosphorylase b (Fig. 3) suggests the 
existence of a direct stoichiometric relationship between 
the monomer (470 kDa) and band b (dimers) and band c 
(tetramers). Band d may represent a pentamer, while the 
trimers are not detectable. Since it is well accepted that the 
ryanodine receptor is a tetramer [5-7,28], the apparent 
pentamer probably represents a tetramer with intrachain 
cross-linking. 
Quantitative analysis of the 470 kDa band and of the 
cross-linking products (shown in Fig. IC) is presented in 
Fig. 4, along with the effect of cross-linking on ryanodine 
binding. As can be seen, the treatment of SR membranes 
with DFDNB leads to a progressive disappearance of the 
ryanodine receptor monomer and to the loss of ryanodine 
binding activity. Half-maximal inhibition of ryanodine 
binding was observed at 50 /xM DFDNB, while a 50% 
loss of the monomer was observed at 10/xM DFDNB, and 
complete ffects with about 250/zM and 50 to 100/zM of 
DFDNB, respectively (Fig. 4A). 
The relative proportions of the 560 kDa intramolecular 
cross-linked monomers (Mx), dimers (D) and tetramers (T) 
as a function of the DFDNB concentration is shown in Fig. 
4B. The intramolecular c oss-linked monomers are first to 
be formed, and are followed by the formation of the 
dimers and tetramers. This may suggest hat the amino 
acid residues involved in the intramolecular c oss-linking 
are more reactive than those involved in the formation of 
dimers and tetramers. Fig. 4B also shows that, as expected, 
the relative amount of the intramolecular cross-linked 
monomers and dimers is decreased upon tetramers forma- 
tion. No linear relationship between the extent of inactiva- 
tion of ryanodine binding and the disappearance of the 
monomer, or the appearance of either one of the cross-lin- 
king products was obtained (data not shown). This may 
suggest hat the inhibition of ryanodine binding is not 
directly due to the cross-linking of the ryanodine receptor. 
The time-and pH-dependence of DFDNB cross-linking 
of RyR together with its ryanodine binding activity is 
shown in Fig. 5. Quantitative analysis of the protein bands 
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Fig. 4. Quantitative analysis of the ryanodine receptor cross-linking products and the relationship between them and the ryanodine binding inhibition. SR 
membranes (1.0 mg/ml)  were treated with the indicated concentration f DFDNB as described in Fig. 1. Aliquots (50 /xg) were subjected to SDS-PAGE 
(3-6% acrylamide) or were assayed for ryanodine binding (20 nM) ((3) as described under Experimental procedures. Quantitative analysis of the 
ryanodine receptor monomers (0 )  in A and of the cross-linking products ( zx, II, A ) in B was carried out as described under Experimental procedures. In
B, the amounts of the cross-linking products relative to that of the ryanodine receptor monomer are plotted. The intramolecular cross-linked tetramer (band 
d) is included in the amount of tetramers. The following symbols: O, II, zx, A indicate: monomers, intramolecular cross-linked monomers (Monomer-X), 
dimers and tetramers, respectively. Ryanodine binding activity (100%) = 8.2 pmol /mg protein. 
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Fig. 5. Cross-linking of the ryanodine receptor with DFDNB as a function of incubation time or pH. (A) SR membranes (1.0 mg/ml)  were incubated 
without or with 20 /xM of DFDNB at pH 8.0 for the indicated time as in Fig. 1. Aliquots (50 /zg) were subjected to SDS-PAGE (3 to 6%) (A, inset) or 
assayed for ryandine binding (20 nM). Quantitative analysis of the ryanodine receptor monomer was carried out as described under Experimental 
procedures. (B) SR membranes (1 mg/ml)  were incubated with DFDNB (20/xM) at different pH values as in Fig. 1. The buffers used were 20 mM Mops 
for pH 6.5, 7.0 and 7.5 and 20 mM Tricine for pH 8.0, 8.5 and 9.0. Quantitative analysis of the monomer (0 )  and ryanodine binding (O)  were carried out 
as described under Experimental procedures. Control activity (100%) was between 7 and 8.2 pmol ryanodine bound/mg protein. 
of exposure to the reagent resulted in progressive inactiva- 
tion of ryanodine binding 01/2 = 30 min) and in the 
disappearance of the ryanodine receptor monomer (t I / 2 = 3 
rain). The pH-dependence of the ryanodine binding inhibi- 
tion and RyR monomer disappearance produced by the 
cross-linking with DFDNB is shown in Fig. 5B. Both the 
disappearance of the 470 kDa protein band and the inacti- 
vation of ryanodine binding increased with the increasing 
of pH in the DFDNB incubation medium. The results how 
a different pH dependency for the inactivation of the 
ryanodine binding and the disappearance of the ryanodine 
receptor monomer produced by DFDNB. The inactivation 
of ryanodine binding is consistent with reaction of an 
ionizable group with a p K a of approx. 8.0, suggesting the 
involvement of lysyl residue in the inactivation of ryan- 
odine binding. The results in Fig. 5 indicate that the 
inactivation of ryanodine binding by DFDNB is not di- 
rectly related to the cross-linking of the ryanodine recep- 
tor. 
The cross-linking of the ryanodine receptor by other 
m 1 ~ o 180 
100, ~ o 150 
~= ~" i , , , '~""~ 30 
'~ 0 
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Fig. 6. Cross-linking of the ryanodine receptor with, glutaraldehyde, DMS and EDC. (A) SR membranes (1 mg/ml)  were incubated for 15 min with the 
indicated concentration of glutaraldehyde (0.0002 to 0.005%) in 20 mM Tricine, pH 8.0 at 37 ° C. (B) SR membranes were incubated for 15 min with the 
indicated concentration of EDC in 50 mM imidazole, pH 7.0 at 30°C (O,  0 )  or 24°C ( / , ,  C]). (C) SR membranes were incubated for 30 min with the 
indicated concentration of DMS in 20 mM Tricine, pH 8.6 at 30 ° C. Aliquots were assayed for ryanodine binding (20 nM) or subjected to SDS-PAGE 
(2.6-6%) and to quantitative analysis as described under Experimental procedures. Control activities (100%) were: 8.3, 5.3 and 2.9 pmol ryanodine 
bound/mg protein, for A, B and C, respectively. 
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bifunctional cross-linking reagents was studied. DFNPS 
has effective length of molecule of 9 A compared to 5 ,~ 
for DFDNB, is also effective in producing the same cross- 
linking products and inactivation of ryanodine binding as 
DFDNB, although igher concentrations (20-300 /xM) of 
the reagent are required. Here also there is no direct 
relationship between the inactivation of ryanodine binding 
and the disappearance of the 470 kDa (data not shown). 
Another reagent shown to react with the purified ryan- 
odine receptor and proposed to form dimers, trimers and 
tetramers i glutaraldehyde [28]. SDS-electrophoretic pat- 
tern of SR membranes treated with glutaraldehyde shows 
five 'new' protein bands (data not shown). According to 
the monomer copy number analysis [22], three of these 
protein bands corresponding to dimer, tetramer and pen- 
tamer which is probably intramolecular cross-linked te- 
tramer. The other two bands, most likely, represent intra- 
molecular cross-linking products with apparent molecular 
mass of 630 kDa and 705 kDa. The ryanodine binding 
activity of these glutaraldehyde tr ated membranes was not 
significantly affected, although the 470 kDa band com- 
pletely disappeared (Fig. 6A). Also, both the ryanodine 
association with -and the dissociation from -its high-or 
low-affinity binding sites were not altered by the cross-lin- 
king of the ryanodine receptor with glutaraldehyde (data 
not shown). It should be mentioned that, in this work, we 
used glutaraldehyde concentrations about 100-times lower 
than those used for cross-linking of the purified ryanodine 
receptor [28] or the SR (Ca 2 +,Mg 2+)-ATPase [24]. 
Cross-linking reactions were also catalyzed with 1- 
ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), a 
water-soluble carbodiimide that forms zero-length covalent 
bonds between carboxyl groups and nucleophilic groups, 
probably amino groups, in contact area between poly- 
peptides or within it [30]. Fig. 6B shows the effect of 
EDC-modification of SR membranes on their ryanodine 
binding activity and on the cross-linking of the ryanodine 
receptor. EDC, at relatively low concentrations, induces 
cross-linking of the ryanodine receptor into several cross- 
linked species. This cross-linking does not impair the 
ryanodine binding activity. 
Dimethyl suberimidate (DMS) reacts specifically with 
amino groups to produce amidine cross-links among the 
protomers of oligomeric proteins where the amido ester 
retains the same charge as the unreacted protein [29]. In 
contrast o DFDNB, DFNPS and glutaraldehyde, DMS at 
pH 8.0 and in concentrations up to 20 mM and incubation 
time up to 60 min at 37°C was ineffective in inhibiting 
ryanodine binding or producing cross-linking products. 
However, increasing the incubation pH to 8.6 resulted in 
cross-linking of the ryanodine receptor with about 30% 
stimulation of ryanodine binding (Fig. 6C). 
Similar results as with glutaraldehyde, with respect o 
the cross linked products and the lack of effect on ryan- 
odine binding to the high-affinity site, were obtained with 
another reagent, the lysyl-specific hydrophobic reagent; 
ethylene glycol bis(succinimidylsuccinate) (EGS) (see Fig. 
10). 
It seems important hat the cross-linking of the ryan- 
odine receptor takes place irrespectively of it being a 
membrane-bound or a purified soluble protein (Fig, 7). As 
shown DFDNB cross-linked the purified ryanodine recep- 
tor to form the intra-and inter-molecular cross-linking, and 
in parallel inhibited ryanodine binding (Fig. 7A). Glu- 
taraldehyde cross-linked the purified receptor with no sig- 
nificant effect on ryanodine binding (Fig. 7B). A monomer 
copy numbers analysis [22] of the results indicates that the 
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Fig. 7. Cross-linking of the purified ryanodine receptor with DFDNB and glutaraldehyde. Purified ryanodine receptor was first separated from DTT and 
sucrose by the chromatography-centrifugation method [37] using Sephadex G-50 pre-equilibrated with 0.2 M NaCI, 0.4% CHAPS and 20 mM Tricine, pH 
8.0. Aliquots 4 to 5.4 ~g were incubated with the indicated concentration of DFDNB (A) or with glutaraldehyde (B) as in Fig. 6. Then the protein samples 
were incubated for 10 min with phospholipids (2 mg/ml )  and then assayed for ryanodine binding (20 riM) (C)) as described previously [ 18] or subjected to 
SDS-PAGE (2.6-6%) and to quantitative analysis (O)  as described under Experimental procedures. Control activity (100%) was: 101 pmol /mg protein. 
(• ) ,  ( zx ) and ( • ) indicate ryanodine binding and the relative amount of RyR, respectively, results from other experiments. Inset shows the SDS-PAGE 
profile of purified RyR incubated without or with 10 or 20 /zM of DFDNB. 
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Table 1 
Effect of prior chemical modification of SR membranes with DNFB or FITC on the cross-linking of the ryanodine receptor with DFDNB 
157 
Treatment 1 Treatment II DFDNB (rain) Ryanodine binding (% of control) Relative amount % of total RyR 
M Mx D T 
(A) Control 0 100 100 0 0 0 
2 66 53 12 26 8 
6 33 8 9 19 36 
10 22 9 6 15 58 
(B) FITC (100 #M) 0 46 100 0 0 (I 
2 20 65 0 8 8 
6 7 18 0 10 31 
10 7 9 0 14 57 
(C) DNFB (120 ~M) 0 16 100 0 0 0 
2 12 8 3 0 0 0 
6 7 49 0 0 19 
10 4 41 0 0 9 
SR membranes (I mg/ml)  were incubated with the indicated concentration of FITC or FDNB for 8 min or 15 rain, respectively, in 20 mM Tricine, pH 8.0 
(treatment I). Aliquots of the FITC-or FDNB-modified membranes were incubated with 20 /.tM DFDNB for the indicated time (treatment I1). Control and 
modified membranes were assayed for ryanodine binding activity and analyzed by SDS-PAGE as described in Fig. 4. Control activity (100%)= 3.7 
pmol/mg protein. M, Mx, D and T indicate: monomers, monomers cross-linked, dimers and tetramers, respectively. 
taraldehyde are the same as those obtained with the mem- 
brane-bound receptor. 
Comparison of the cross-linking of the RyR by the 
different bifunctional reagents as reflected by the appear- 
ance of the various cross-linking products and by their 
effects on ryanodine binding may suggest hat the inhibi- 
tion of ryanodine binding by DFDNB and DFNPS is due 
to the formation of the 560 kDa cross-linked product, or 
due to modification of an essential amino group(s) by the 
reagents. To modify amino groups with no cross-linking of 
the RyR, we used two monofunctional reagents that react 
with selectivity for amino groups. We have shown recently 
[31] that fluorescein 5'-isothiocyanate (FITC) a lysyl- 
specific reagent, interacts with the ryanodine receptor, 
inhibited ryanodine binding and promoted the appearance 
of an open Ca 2+ release channel with sub conductance 
states. The effect of prior chemical modification of the 
ryanodine receptor with the monofunctional reagent, FITC, 
on the cross-linking of the 470 kDa by DFDNB is shown 
in Table 1. FITC modification diminished the formation of 
the 560 kDa cross-linked product. The appearance of the 
dimers and the other two high molecular masses cross-lin- 
king products was only slightly affected by this FITC 
modification. Table 1 also shows that prior modification of 
the ryanodine receptor with another monofunctional 
reagent; DNFB which inhibits ryanodine binding followed 
by treatment with DFDNB, resulted in a decrease in the 
disappearance of the ryanodine receptor monomer and in 
the appearance of the cross-linking products produced by 
cross-linking with DFDNB. These results suggest hat the 
inhibition of ryanodine binding by DFDNB is due to 
modification of a lysyl residue(s), similarly to the effect of 
FITC [31]. This conclusion is supported by the observation 
that FITC inhibits ryanodine binding in SR membranes 
where the RyR is crossed-linked with glutaraldehyde (data 
not shown). These results suggest hat in addition to its 
cross-linking activity, DFDNB acts similarly to FITC [31], 
modifies an amino group(s) essential for ryanodine bind- 
ing. 
Fig. 8 shows the effect of DFDNB modification of 
junctional SR membranes on their ryanodine binding affin- 
ity (K d) and the total binding sites (Bm~,x). K d values of; 
IO f y •  1 1 
n A 0.8 
" 6 F . , , "  0.6 
4[-  / ~  (1o) 
0.4 
0~ ' - .  i , i , i , 0 
• B 
"N .  
I I I 
0 10 20 30 40 2 4 6 8 l0 
Ryanod ine  ,nM Ryanod ine  bound , pmol /mg 
Fig. 8. The influence of DFDNB modification on the affinity and number of the high affinity ryanodine binding sites. HSR membranes were incubated 
without (O, O)  or with DFDNB: 10 (• ) ,  25 (/x) or 50 (• )  /*M, as in Fig. 1, and then ryanodine binding was assayed as a function of its concentration 
as described in Experimental procedures. Saturation isotherms are shown in (A) and Scatchard plots in (B). 
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13.5, 12.5, 12, and 14 nM were obtained for control and 
membranes modified with 10, 25, and 50 /zM of DFDNB, 
respectively. The total high-affinity binding sites, however, 
were decreased with increasing DFDNB concentration from 
13.6 for control to 7.9, 4.3, and 2.6 pmol/mg protein for 
membranes modified with 10, 25, and 50/xM of DFDNB, 
respectively. 
The results illustrated in Fig. 9 are consistent with the 
suggestion that in addition to its cross-linking activity, 
DFDNB similar to FITC [31], stimulates Ca 2- efflux from 
SR vesicles. Modification of SR membranes with DFDNB, 
but not with glutaraldehyde, resulted in a stimulation of 
Ca 2÷ efflux from SR vesicles passively loaded with 
45CAC12. Fig. 9 also shows that DFDNB modification, 
which results in inhibition of ryanodine binding, dimin- 
ished the activation of Ca 2+ effiux by ryanodine. In con- 
trast, glutaraldehyde which has no significant effect on 
ryanodine binding affects the ryanodine-induced Ca 2÷ ef- 
flux only slightly (Fig. 9B). Since the RyR was crossed 
linked almost completely (about 90%) by glutaraldehyde, 
these results suggest hat the cross-linking of the RyR is 
not responsible for the activation of Ca 2 ÷ efflux produced 
by DFDNB. As suggested for the inhibition of ryanodine 
binding by DFDNB modification, the activation of Ca 2+ 
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Fig. 10. Cross-linking of the ryanodine receptor with glutaraldehyde (A) 
and EGS (B) inhibits ryanodine binding to the low-but not to the 
high-affinity sites. (A) SR membranes were treated with the indicated 
concentrations of glutaraldehyde as in Fig. 6 or were incubated with the 
indicated concentration of EGS as described under Experimental proce- 
dures. Ryanodine binding to the unmodified and EGS-or glutaraldehyde- 
modified membranes were assayed as described under Experimental 
procedures in the presence of 20 nM (0 )  or 2 /zM (©) of ryanodine. 
[3H]Ryanodine (60 Ci /mmol)  was diluted with unlabeled ryanodine 1:3 
or 1:25 for 20 nM and 2 /xM, respectively. Non-specific binding was 
determined in the presence of 500-fold excess of unlabeled ryanodine. 
Control activities (100%) were for A: 6.2 and 23 and for B: 4.3 and 20 
pmol /mg protein for 20 nM and 2 /xM of ryanodine, respectively. The 
dashed lines represent the results with 2 p,M ryanodine after subtracting 
the binding to the high-affinity site. At the highest concentrations of
glutaraldehyde or EGS used, RyR monomer was completely cross linked 
(not shown). 
(O) Control SR (O) Control SR 
A (I) Control SR + Ry ~ 0  (11) Control SR ÷ Ry 
(A) DIrDNB. modlned SR (0) GA- modified SR 
120 . (o) DFDNB- modified SR + Ry 120 (A) GA- modified SR + Ry 
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Fig. 9. Effect of cross-linking of RyR with DFDNB and glutaraldehyde 
on the membrane permeability for Ca 2+ and on the activation of Ca 2+ 
release by ryanodine. SR vesicles were incubated without (C)) or with 
DFDNB (60/~M) ( ,x, [] ) (A) or with glutaraldehyde (400/xM) (0 ,  • ) 
(B) for 15 min as described in Experimental procedures. Aliquots were 
assayed for ryanodine binding activity or subjected to SDS-PAGE. For 
passive loading with 45CAC12, the membranes were collected by centrif- 
ugation (40000× g, 30 min) and resuspended (2 mg/ml)  in a medium 
containing 0.3 M KC1, 20 mM Mops, pH 6.8 and 0.4 mM CaC12 
(containing 45CaCl2 5.104 cpm/nmol),  and incubated for 90 min at 
24 ° C. Ryanodine to a final concentration of 0.5 /xM was added to 
aliquots of the Ca 2+ loaded vesicles of control (11), DFDNB (153) and 
glutaraldehyde-treated SR (• ) ,  and then the membranes were incubated 
for additional 30 min. Ca 2+ efflux assay was carried out as described 
previously [40], the loaded vesicles (20 /xl) were placed on 0.45 /xm 
nitrocellulose filters and the efflux was initiated by rinsing with different 
volumes of 0.3 M KC1, 20 mM Mops, pH 6.8 and 1 mM EGTA solution 
for the indicated time. The flow rate was 1 ml/s .  Ryanodine binding 
activities were: 9.7, 3.5 and 9.4 pmol /mg protein for control, DFDNB-and 
glutaraldehyde-treated membranes, respectively. Ca 2+ content of the 
loaded SR (100%) was: 9 nmol /mg protein. 
amino group(s) in the RyR. This is similar to previous 
results obtained with FITC modification [31]. 
Fig. 10 illustrates the inhibitory effect of cross-linking 
of the membrane-bound RyR with glutaraldehyde or EGS 
on its ryanodine binding to the low-affinity sites. Both 
reagents have no effect on ryanodine binding to the high- 
affinity site, but inhibit the binding to the low-affinity 
sites. Although the RyR monomer was completely disap- 
peared (data not shown), ryanodine binding to the low-af- 
finity site was only partially inhibited. The results from 
other experiments indicate that cross-linking of the RyR 
with glutaraldehyde has no significant effect on the K d 
(16.5 ___ 2.5 and 16.3 + 3.7 nM for control and glutaralde- 
hyde SR, respectively) and on the Bma x (16.5 + 0.5 and 
13.7 ___ 1.4 pmol/mg for control and glutaraldehyde SR, 
respectively) of the high-affinity ryanodine binding site, 
but this cross-linking decreased the binding of ryanodine 
to the low-affinity sites. Thus, the low-affinity but not the 
high-affinity ryanodine binding sites were altered by the 
cross-linking of the ryanodine receptor with glutaraldehyde 
and EGS. 
4. Discussion 
The relationship between the tetrameric organization of 
the ryanodine receptor and its ryanodine binding and Ca 2 + 
release activities were approached through cross-linking 
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Fig. 1 I. Schematic model for the formation of dimers and tetramers but 
not trimers. A and B represent amino acid residues with different 
reactivity owards the cross-linking reagents. 
studies using several bifunctional reagents. Under the con- 
ditions used here, treatment of SR membranes with several 
bifunctional cross-linking reagents resulted in cross-linking 
of the RyR, but of almost no other SR proteins. Cross-lin- 
king with DFDNB, DFNPS, DMS, EDC, EGS and glu- 
taraldehyde r sulted in the appearance of additional protein 
bands in the SDS-electrophoretograms, which corre- 
sponded approximately to the dimer and tetramer of the 
RyR subunits. These protein bands cross react with anti- 
bodies prepared against the 470 kDa protein band (RyR 
subunits) (Fig. 2), but not with antibodies against the 
Ca 2 +-ATPase, sarcalumenin ortriadin. However, two bands 
are visible at the position of the tetramer (Figs. 1 and 2) 
where the upper band, according to monomer copy num- 
bers analysis [22] (Fig. 3), corresponds to pentamer. Since 
it is well accepted that the ryanodine receptor is a tetramer 
[5-7,28], this observation could be explained by assuming 
that the tetramer-forming protomers are cross-linked in 
two different ways (see Fig. 11 tetramer (A) and tetramer 
(B)), one of which migrates as a species with higher 
apparent molecular mass. It is also possible that within 
each molecular weight category, there is a variety of 
species with different numbers of intra-and interchain 
cross-links. An additional band with M r of 560000 was 
obtained with DFDNB and DFNPS but not with EDC, 
DMS, EGS and glutaraldehyde. This band is probably 
formed by intrapeptide cross-linking, which alters the hy- 
drodynamic properties of the monomer. A similar phe- 
nomenon has been shown for other proteins [23,24]. It is 
possible that more than one type of cross-linking is respon- 
sible for the formation of the 560 kDa. However, the 
generation of the 560 kDa cross-linking product could be 
also attributed to cross-linking of the RyR monomers (470 
kDa) and an unidentified protein(s) (other than the Ca 2÷- 
ATPase, sarcalumenine or triadin) associated with the 
'foot' structure complex. Given the fact that the formation 
of dimers precedes that of tetramers (Figs. 4 and 5), and 
assuming that the reacting residues in the homotetramers 
are equally reactive towards the cross linkers, the absence 
of detectable trimers is expected. Indeed, occurrence of a 
single additional cross link between two dimers would lead 
to the formation of a tetramer (see Fig. 11). 
The SDS-electrophoretic patterns of the purified cross- 
linked RyR resemble those of the membrane-bound recep- 
tor (Fig. 7). This is not surprising, since the major part of 
the ryanodine receptor molecule protrudes from the mem- 
brane [ 13], thus the accessibility of soluble and membrane 
bound RyR to cross-linking reagents in solution should be 
rather similar. The fact that the CHAPS-solubilized, puri- 
fied ryanodine receptor is also cross-linked with DFDNB 
and glutaraldehyde supports the concept [5-7,28] that 
ryanodine receptor is an oligomer both in the solubilized 
and membrane bound forms, and that the soluble-purified- 
protein preserves the native structure of the complex. 
Comparison of cross-linking using a zero length cross- 
linker; EDC, and DFDNB, whose approximate dimension 
between the two reactive groups is of 5 A [21], indicates a
tight contact between the subunits in the tetramer. Cross- 
linking is also observed with EGS, DFNPS and with DMS 
which have effective lengths of 6.4 ,~,, 9 A and 11 A, 
respectively [21]. The approximate distance between the 
glutaraldehyde r active groups could not be estimated, 
because at neutral or slightly basic pH, the predominant 
reactive species of glutaraldehyde is the o~,/3-unsaturated 
aldehyde polymers, where the number of monomers is 
increased, as the pH is raised [34]. These results suggest 
that there is no critical distance between the ryanodine 
receptor reactive groups towards the bifunctional reagents, 
and that they are probably located in the protein, so they 
are accessible to both uncharged reagents (DFDNB, 
DFNPS), and to the charged DMS at alkaline pH (8.6). 
The finding that prior chemical modification with FITC, or 
FDNB which are specific for lysyl residues decreased the 
appearance of the cross-linked products (Table 1) impli- 
cates the involvement of lysyl residues in this cross-lin- 
king. 
Our results show that ryanodine binding to the high-af- 
finity site was not altered upon cross-linking of the ryan- 
odine receptor with glutaraldehyde, DMS, EGS or EDC 
(Figs. 6, 7 and 10). No correlation was found between the 
disappearance of the RyR monomer or the appearance of 
its cross-linking products, and the inhibition of ryanodine 
binding produced by DFDNB and DFNPS (Figs. 4, 5 and 
7). These observations suggest hat cross-linking of the 
RyR to produce dimers or tetramers does not interfere with 
its ryanodine binding activity to the high-affinity site. On 
the other hand, the results may suggest hat the 560 kDa 
cross-linked product produced by DFDNB and DFNPS is 
responsible for the inactivation of ryanodine binding. 
However, it is unlikely that the intramolecular c oss-lin- 
king by itself causes the inactivation of ryanodine binding, 
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but rather the modification of a specific lysyl residue(s). 
We have recently shown that modification of SR mem- 
branes with FITC (modifies a lysyl residue(s)) resulted in 
inhibition of ryanodine binding and activation Ca 2 +-release 
channels [31]. Similarly, DFDNB inhibits ryanodine bind- 
ing and stimulates Ca 2+ effiux from SR passively loaded 
with 45CAC12 (Fig. 9). Also, as with FITC [31], DFDNB 
modification decreases the total high-affinity ryanodine 
binding sites with no significant effect on the ryanodine 
binding affinity (Fig. 8). 
Ryanodine receptor possesses, in addition to the high- 
affinity ryanodine binding site, 2 to 3 binding sites of 
lower affinity [28,32,33]. It has been suggested that the 
ryanodine receptor exhibits 'positive cooperativity' where 
binding at the low-affinity sites decreases the dissociation 
rate of ryanodine from the high-affinity site [28,32]. A 
model for the allosteric negative cooperativity between the 
four ryanodine binding sites in the homotetramer RyR was 
recently proposed [33]. The model suggests that the bind- 
ing of ryanodine to one of the four sites (with high 
affinity) triggers the conversion of the other sites to low 
affinity(ies) binding sites. According to Monod et al. [35], 
this suggests that in order for RyR to manifest binding 
cooperativity, there must be two or more different states of 
the receptor with different affinities. Also, the protein must 
undergo a conformational change(s) in each subunit. In 
light of the allosteric interaction between the RyR subunits 
[28,32,33], the observation that 'f ixation' of the RyR in 
irreversible tetrameric structure(s) do not affect its ryan- 
odine binding to the high-affinity site is of interest. Ryan- 
odine binding is CaZ+-dependent and the complex [Ca 2+. 
RyR] is a very stable complex from which ryanodine is 
dissociated very slowly ( t l /2  of 14.4 h [36]). This would 
suggest hat RyR undergoes conformational changes upon 
Ca 2+ and/or  ryanodine binding, where in the 'new' con- 
formation, ryanodine is physically occluded and hindered 
from free diffusion from its binding site. Thus, the cross- 
linking of 2 or more residues in each monomer (which 
lead to fixation of dimers or tetramers) does not prevent 
the conformational changes involved in binding and occlu- 
sion of ryanodine at the high-affinity site. On the other 
hand, cross-linking of the RyR with glutaraldehyde or EGS 
results in a partial inhibition of ryanodine binding to the 
low-affinity binding sites (Fig. 10) due to a decrease in the 
number of the low-affinity sites. 
In conclusion, we have described in this article covalent 
cross-linking of the RyR by six different bifunctional 
reagents, differing in their linear dimensions and flexibil- 
ity, as well as in the reactivity of the active groups. A 
linkage between the RyR subunits to form irreversible 
dimers or tetramers does not affect its ryanodine binding to 
the high-affinity site, but inhibits the binding to the low-af- 
finity sites. We anticipate that further investigation should 
provide important insights into the conformational changes 
involved in the Ca2+-dependent ryanodine binding to both 
the high- and the low-affinity binding sites. 
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